Ocuphire Pharma (OCUP)
(Delayed Data from NSDQ)
$1.54 USD
+0.01 (0.33%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.53 -0.01 (-0.33%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.18 |
EPS Last Quarter | -0.21 |
Last EPS Surprise | -200.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.53 |
Next Year | -0.42 |
EPS (TTM) | -0.48 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.01M | 3.43M | 15.11M | 30.62M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 3.01M | 3.43M | 15.11M | 30.62M |
Low Estimate | 3.01M | 3.43M | 15.11M | 30.62M |
Year ago Sales | 1.75M | 3.67M | 19.05M | 15.11M |
Year over Year Growth Est. | 72.00% | -6.54% | -20.68% | 102.65% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.18 | -0.18 | -0.53 | -0.42 |
# of Estimates | 1 | 1 | 2 | 1 |
Most Recent Consensus | -0.18 | -0.18 | -0.31 | -0.42 |
High Estimate | -0.18 | -0.18 | -0.31 | -0.42 |
Low Estimate | -0.18 | -0.18 | -0.74 | -0.42 |
Year ago EPS | -0.28 | -0.24 | -0.46 | -0.53 |
Year over Year Growth Est. | 35.71% | 25.00% | -15.22% | 19.81% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.18 | -0.18 | -0.53 | -0.42 |
7 Days Ago | -0.18 | -0.18 | -0.53 | -0.42 |
30 Days Ago | -0.18 | -0.18 | -0.53 | -0.42 |
60 Days Ago | NA | NA | -0.57 | -0.31 |
90 Days Ago | NA | NA | -0.57 | -0.31 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.18 | -0.53 | -0.42 |
Zacks Consensus Estimate | -0.18 | -0.18 | -0.53 | -0.42 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.21 | 0.25 | -0.24 | -0.28 | NA |
Estimate | -0.07 | -0.32 | -0.36 | -0.24 | NA |
Difference | -0.14 | 0.57 | 0.12 | -0.04 | 0.13 |
Surprise | -200.00% | 178.13% | 33.33% | -16.67% | -1.30% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more